Tergene Biotech gets recommendation from CDSCO subject expert committee for pneumococcal 15-valent vaccine
Shortpedia
Content Team
Image Credit: money control
Aurobindo Pharma Ltd. announced that the Central Drugs Standard Control Organization's (CDSCO) topic expert committee has recommended the pneumococcal 15-valent (PCV15) vaccine to its joint venture company, Tergene Biotech. Aurobindo Pharma Vice Chairman & Managing Director K Nithyananda Reddy said, SEC's recommendation is based on data from trials conducted in 1,130 pediatric subjects assessing safety, tolerability, and immunogenicity.
